spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  Cancer Immunotherapeutic 

 HSMN NewsFeed - 20 Apr 2018
SELLAS Life Sciences Announces Appointment of Gene Mack as Chief Financial Officer & Treasurer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 May 2017
Regeneron and Inovio Enter Immuno-Oncology Clinical Study Agreement for Glioblastoma Combination Therapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Oct 2016
SELLAS(TM) Life Sciences Appoints Former Barclays Biotechnology Research Analyst as Chief Business and Strategy Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Sep 2016
Dynavax Provides Regulatory Update on HEPLISAV-B
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Oct 2015
Fate Therapeutics Announces Leadership Transition
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Jul 2015
Fate Therapeutics Appoints Dr. Stewart Abbot as Vice President, Translational Research
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Dec 2014
Crescendo Biologics' Receives Further Investment from Astellas Venture Management to Develop Novel Humabody(TM) Therapeutics Targeting Immune Checkpoint Inhibitors
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 9 Jun 2014
Batu Biologics Announces FDA Development Plans for ValloVax(TM) Angiogenesis-Targeting Cancer Vaccine
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Mar 2014
Tocagen Names Jamey Skillings, M.D., Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Mar 2014
Immune Design Appoints William Ringo to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Sep 2013
GSK’s MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Melanoma Misses First Co-Primary Endpoint
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Nov 2012
Novel Cancer Immune Therapy Developer Oncos Therapeutics Appoints Experienced Industry Leader Frans Wuite as President and CEO
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Nov 2012
Vical Names Mammen P. Mammen, Jr., M.D., Vice President, Clinical Vaccines
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Sep 2011
Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Oct 2010
Vical Names Igor Bilinsky Senior Vice President, Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jun 2010
Galera Therapeutics Secures Funding for New Cancer Treatment
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 3 Mar 2010
Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy
Diagnostics Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Mar 2009
MannKind Submits NDA for AFRESA for Treatment of Diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 22 Sep 2008
CytRx Corporation Completes Acquisition of Innovive Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Jun 2008
CytRx Corporation Signs Definitive Agreement to Acquire Innovive Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 May 2008
New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Sep 2007
Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
Biopharmaceuticals
 HSMN NewsFeed - 20 Aug 2007
Vical Names Andrew de Guttadauro Vice President, Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jun 2007
Encouraging Clinical Activity of GSK's Novel Cancer Immunotherapeutic Confirmed in Phase II Study in Patients with Most Common Form of Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Jun 2007
Biovest to File for Accelerated Conditional Approval of BiovaxID
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 May 2007
Vical's Vaxfectin(TM) Adjuvant With Needle-free Delivery Enhances DNA Vaccine Performance; Yields Antibody Responses Comparable to Electroporation Without Tolerability Issues
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 24 Jan 2007
Vical Highlights Transition to Phase 3 Trial With Allovectin-7(R) for Metastatic Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Jan 2007
Vical Initiates Pivotal Phase 3 Trial of Allovectin-7(R) as First-line Therapy for Metastatic Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Dec 2006
INNOVIVE Pharmaceuticals Presents Data on Oncology Drug Programs in Chronic Myelogenous Leukemia and Acute Myelogenous Leukemia at American Society of Hematology 48th Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Jul 2006
Vical Announces Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jul 2006
Antigenics Announces Expansion of Its License and Supply Agreement With GlaxoSmithKline Biologicals for QS-21 Stimulon(R) Adjuvant
Biopharmaceuticals Licensing
 HSMN NewsFeed - 4 May 2006
Biovest International Announces Addition to Senior Management Team
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 10

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 10 additional stories matching:
Cancer Immunotherapeutic
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!